On this page
- TL;DR
- How VA Rates Active Psoriatic Arthritis Under DC 5002
- When VA Rates Chronic Joint Residuals Instead
- The correct comparison is therefore:
- Why Psoriasis and Psoriatic Arthritis Are Not the Same Rating
- What Evidence Documents the Active Process
- Service Connection Without Automatic Nexus Claims
- Common Failure Modes
- Bottom Line
- Related Conditions and Tools
Psoriatic arthritis is expressly included in Diagnostic Code 5002, the active-process code for multi-joint arthritis involving two or more joints. Current 38 CFR § 4.71a creates two possible rating paths: rate the active systemic disease under DC 5002, or rate chronic residuals under DC 5003 and the appropriate joint codes. VA does not add the two paths together. It assigns the higher evaluation.
That distinction matters because an inflammatory flare history and permanent joint damage prove different things. A one-day range-of-motion exam may document residual damage but miss the frequency and severity of the active disease. A useful record has to show both.
TL;DR
- DC 5002 covers active psoriatic arthritis affecting two or more joints.
- The active-process levels are 20, 40, 60, and 100 percent.
- Chronic residuals are rated under DC 5003 and, when applicable, the limitation-of-motion or ankylosis code for each affected joint.
- Active-process and residual evaluations do not stack. VA must compare them and assign the higher evaluation.
- Psoriasis of the skin is a separate diagnosis under DC 7816. Separate compensation still requires distinct manifestations rather than double payment for the same impairment.
- Service connection requires evidence for the individual veteran. Combat stress, toxic exposure, PTSD, or depression should not be presented as automatic causes of psoriatic arthritis.
- No verified aggregate Board-outcome cut specific to psoriatic arthritis was available, so this page does not publish a grant-rate statistic.
How VA Rates Active Psoriatic Arthritis Under DC 5002
DC 5002 provides four active-process levels:
20 percent
One or two exacerbations per year in a well-established diagnosis.
40 percent
Symptom combinations that produce definite impairment of health and are objectively supported by examination findings, or incapacitating exacerbations occurring three or more times per year.
60 percent
Less than the 100-percent criteria, but with weight loss and anemia producing severe impairment of health, or severely incapacitating exacerbations occurring four or more times per year, or fewer exacerbations that continue over prolonged periods.
100 percent
Constitutional manifestations associated with active joint involvement that are totally incapacitating.
These levels focus on the disease over time. Treatment notes should identify how many exacerbations occurred, how long they lasted, whether they were incapacitating, and whether the disease caused objectively documented impairment of overall health. A statement that the veteran “has flares” does not establish the frequency or severity required by the schedule.
When VA Rates Chronic Joint Residuals Instead
DC 5002 Note (2) directs VA to rate chronic residuals under DC 5003. Note (3) then says the active-process rating cannot be combined with ratings for limitation of motion, ankylosis, or DC 5003. VA must use the higher evaluation.
For residuals, identify every joint that has chronic limitation or ankylosis and document it under that joint's code. When limitation of motion is present but not compensable under the joint-specific code, DC 5003 may provide a minimum rating when its objective requirements are met. The exact result depends on the affected joints, measured motion, painful motion, ankylosis, and the bilateral-factor rules when paired extremities are involved.
The correct comparison is therefore:
- Calculate the active-process evaluation under DC 5002.
- Calculate the chronic-residual evaluation under DC 5003 and the appropriate joint codes.
- Assign the higher route without combining both.
Why Psoriasis and Psoriatic Arthritis Are Not the Same Rating
Psoriasis is a skin disease evaluated under DC 7816. Psoriatic arthritis is the inflammatory joint disease described in DC 5002. A veteran can have both diagnoses, but the record must identify distinct manifestations.
Skin coverage and treatment route support the psoriasis analysis. Joint exacerbations, systemic impairment, limited motion, and ankylosis support the arthritis analysis. The anti-pyramiding rule in 38 CFR § 4.14 prevents duplicate compensation for the same functional loss, but it does not erase genuinely separate skin and joint impairment.
What Evidence Documents the Active Process
Useful records include:
- the rheumatology diagnosis and the joints involved;
- treatment notes distinguishing active inflammation from chronic residual damage;
- a dated flare or exacerbation log;
- urgent-care, emergency, or physician records from severe exacerbations;
- laboratory and examination findings that objectively support impairment of health;
- weight and anemia records when those findings are part of the claimed level;
- medication history, including dose changes and treatment failures; and
- lay statements describing duration and functional impact without trying to make a medical diagnosis.
For residuals, preserve joint-specific range-of-motion testing, painful-motion findings, imaging, ankylosis findings, and functional loss during repeated use or flares. The active and residual records should be developed together even though the resulting evaluations do not stack.
Service Connection Without Automatic Nexus Claims
Direct service connection under 38 CFR § 3.303 requires a current disability, an in-service disease, injury, event, or onset, and a link between the two. Service treatment records showing inflammatory joint findings, psoriasis with evolving joint symptoms, dactylitis, enthesitis, nail changes, or a rheumatology assessment can be important, but a clinician must interpret their relationship to the current diagnosis.
A secondary claim under 38 CFR § 3.310 needs competent evidence that a service-connected disability or its treatment caused or aggravated the psoriatic arthritis. An association or shared diagnosis is not enough by itself.
Do not treat combat stress, burn-pit exposure, PTSD, or depression as established medical causes simply because they appear in the veteran's history. A case-specific medical opinion must explain the proposed mechanism, timing, and competing causes. This page also does not assume that the ordinary one-year arthritis presumption applies to every psoriatic-arthritis claim; that question should be reviewed against the precise diagnosis and current authority in the individual case.
Common Failure Modes
- Rating only joint motion and never evaluating the active disease under DC 5002.
- Counting active-process and residual ratings together.
- Describing flares without dates, duration, frequency, or objective support.
- Treating psoriasis skin symptoms as proof of the arthritis percentage.
- Assigning every painful joint to psoriatic arthritis without medical attribution.
- Presenting a stress, exposure, or mental-health theory as an automatic nexus.
Bottom Line
Psoriatic arthritis has a two-path rating structure. DC 5002 rates the active multi-joint disease at 20, 40, 60, or 100 percent. Chronic residuals are rated through DC 5003 and the affected-joint codes. VA must calculate both paths and assign the higher, not stack them. The strongest record separates active exacerbations, permanent joint damage, and psoriasis skin manifestations, then supports service connection with evidence specific to the veteran.
Related Conditions and Tools
Compare psoriasis, arthritis, and rheumatoid arthritis. Review DC 5002 and DC 5003, and organize functional evidence with the Statement Builder.
Legal sources: 38 CFR § 4.71a, § 4.14, § 3.303, and § 3.310, checked August 17, 2026.